Structure | Cat No. | Product Name | CAS No. | Product Description |
---|---|---|---|---|
![]() |
V12968 | BMS-919373 | 1272353-82-8 | BMS-919373 is a Potassium channel Kv1.5 (KCNA5) inhibitor for use in atrial fibrillation and acute coronary syndromes. |
![]() |
V12969 | BMS-929075 | 1217338-97-0 | BMS-929075 is a potent orally bioactive palm site allosteric inhibitor of HCV (hepatitis C virus) NS5B replicase. |
![]() |
V12970 | BMS-932481 | 1263871-36-8 | BMS-932481 is a novel and potent γ-secretase modulator |
![]() |
V12971 | BMS-933043 | 1221973-93-8 | BMS-933043 is a novel and potent α7 nAChR Partial Agonist |
![]() |
V15284 | BMS-955176 (GSK-3532795) | 1392312-45-6 | GSK3532795, formerly known as BMS955176, is a potent, orally bioavailable, second-generation HIV-1 maturation inhibitor (MI) that advanced through phase IIb clinical trials. |
![]() |
V13470 | BMS-955176 HCl | 2023808-13-9 | GSK3532795 HCl, formerly known as BMS955176, is a potent, orally bioavailable, second-generation HIV-1 maturation inhibitor (MI) that advanced through phase IIb clinical trials. |
![]() |
V15285 | BMS-955176 TFA | 2097784-79-5 | GSK3532795 TFA, formerly known as BMS955176, is a potent, orally bioavailable, second-generation HIV-1 maturation inhibitor (MI) that advanced through phase IIb clinical trials. |
![]() |
V12972 | BMS-955829 | 1375751-08-8 | BMS-955829 is a novel and potent Positive allosteric modulators (PAMs) |
![]() |
V6241 | BMS-960 free base | 1265321-86-5 | BMS-960 free base is a potent and selective S1P1 receptor agonist containing isoxazole, which can be used for research on immune diseases and vascular diseases[1] |
![]() |
V12973 | BMS-961955 | 1431328-92-5 | BMS-961955 is a novel and potent inhibitor of NS5B polymerase |
![]() |
V5682 | BMS-962212 | 1430114-34-3 | BMS-962212 is a novel, reversible, direct, and selective inhibitor of factor XIa (FXIa). |
![]() |
V6662 | BMS-986034 | 1492631-88-5 | BMS-986034 is a novel and potent GPR119 agonist |
![]() |
V12977 | BMS-986104 HCl | 1622180-39-5 | BMS-986104 HCl is a selective S1P1 receptor partial agonist. |
![]() |
V12978 | BMS-986115 | 1584647-27-7 | BMS-986115 (Notch inhibitor 1) is a potent Notch inhibitor (antagonist) with IC50s of 7.8 and 8.5 nM for Notch 1 and Notch 3 respectively. |
![]() |
V12979 | BMS-986118 | 1610562-74-7 | BMS-986118 is a potent, orally bioactive, selective GPR40 agonist with EC50 of 0.07 µM. |
![]() |
V8558 | BMS-986122 | 313669-88-4 | BMS-986122 is a potent and selective positive allosteric modulator (PAM) of the μ-opioid receptor (μ-OR). |
![]() |
V12981 | BMS-986124 | 1447968-71-9 | BMS-986124 is a novel, potent and allosteric modulator of the μ-Opioid Receptor. |
![]() |
V12984 | BMS-986187 | 684238-37-7 | BMS-986187 is a delta opioid receptor-selective positive allosteric modulator (PAM) with EC50 of 0.03 μM and a pKB of 6.02 (~1 μM). |
![]() |
V5752 | BMS-986188 | 1776115-10-6 | S-986188 is a selective positive allosteric modulator (PAM) of delta opioid receptors with EC50 of 0.05 μM. |
![]() |
V12902 | BMS22 | 445479-97-0 | BMS22 (BMS-22; BMS CCR2 22) is a novel and potent CCR2 (CC-type chemokine receptor 2) antagonist with anti-inflammatory activity. |